How long does it take for platinib targeted drug to become resistant?

Platinib is a targeted therapy drug that targets specific cancer gene mutations and is mainly used to treat lung and thyroid cancer. As a third-generation RET inhibitor, it reduces the proliferation and spread of cancer cells by highly selectively inhibiting RET receptors on the surface of cancer cells. However, as patients use it longer, drug resistance has gradually become a focus of concern for patients and doctors.

As for how long it will take for platinib to develop resistance, this is not a fixed time. According to publicly released information, resistance to platinib may develop after 9 to 11 months of taking it, but this time frame is not absolute. Because of individual differences, disease severity, and treatment options, the emergence time of drug resistance will vary. Some stronger patients may develop resistance after taking it for a longer period of time, while patients who are frail or have poor absorption of the drug may develop resistance earlier.

The mechanisms of drug resistance are also multifaceted, including but not limited to gene mutations, activation of bypass signals, and increased expression of drug pumps. These changes may cause the original targeted therapy drugs to lose their inhibitory effect on tumor cells, causing tumors to start growing and spreading again.

In response to the problem of resistance to platinib, doctors and researchers are constantly exploring new treatment strategies. This may include changing drug doses, combining other drugs, or switching treatment regimens to delay the development of resistance and maintain treatment effectiveness.

In summary, platinib, as a highly efficient targeted therapy drug, plays an important role in the treatment of lung and thyroid cancer. However, the emergence of drug resistance is a concern. Patients and doctors should pay close attention to the effects of treatment and adjust treatment plans in a timely manner to deal with possible drug resistance issues. With the continuous advancement of science and technology, I believe there will be more effective methods to solve the problem of resistance to platinib in the future and provide patients with better therapeutic effects.